efeitos da inibição do sistema renina-angiotensina-aldosterona e do ...
efeitos da inibição do sistema renina-angiotensina-aldosterona e do ...
efeitos da inibição do sistema renina-angiotensina-aldosterona e do ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
FRANTZ, L.P.et al. Carvedilol therapy is associated with a sustained decline in brain<br />
natriurético peptide levels in patients with congestive heart failure. Am Heart J, Lon<strong>do</strong>n,<br />
v.149: p.541-7, 2005.<br />
FREEDMAN, N.J.; LEFKOWITZ, R.J. Antiß1-adrenergic receptor antibodies and heart<br />
failure: causation, not just correlation. J Clin Invest, Thorofare, v.113: p.1379-1382, 2004.<br />
FREITAS, H. et al. β-Blockers for Chagas`s Heart disease: the reduction in heart rate may<br />
not be associated to improvement in left ventricular ejection fraction and remodeling<br />
process. JACC, New York, Abstracts 184 A – Heart Failure, 1999.<br />
FU, L.X. Ant- M2 muscarinic receptor autoantibodies and idiopatic dilated<br />
cardiomyopathy. Int J Cardiol, Sidney, v.54: p.127-135, 1996.<br />
GEIC - Grupo de Estu<strong>do</strong>s de Insuficiência Cardíaca; Socie<strong>da</strong>de Brasileira de Cardiologia.<br />
Revisão <strong>da</strong>s II Diretrizes <strong>da</strong> Socie<strong>da</strong>de Brasileira de Cardiologia para o Diagnóstico e<br />
Tratamento <strong>da</strong> Insuficiência Cardíaca. Arq Bras Cardiol, São Paulo, v.79: p.IV:1-30,<br />
2002.<br />
GHEORGHIADE, M.; BONOW, R.O. Introduction and overview: beta-blocker therapy in<br />
the management of chronic heart failure. Am J Med, New York, v.110(suppl 7A): p.1S-<br />
5S, 2001.<br />
GIL, P. et al. Cardio-renal insufficiency: the search for management strategies.<br />
Curr Opin Nephrol Hypertens, Philadelphia, v.14;n.5: p.442-7, Sept 2005.<br />
GOIN, J.C. et al. Identification of antibodies with muscarinic cholinergic activity in<br />
human Chagas' disease. J Auton Nerv Syst, [s.l.], v.47: p.45-52. Abstract, 1994.<br />
GOIN, J.C. et al. Interaction of human chagasic IgG with the second extracellular loop of<br />
the human heart muscarinic acetylcholine receptor: functional and pathological<br />
implications. FASEB J, [s.l.], v.11: p.77–83, 1997.<br />
GUIMARÃES, A.C. Aspectos eletrocardiográficos <strong>da</strong> cardiopatia crônica. Cardiopatia<br />
chagásica. Cança<strong>do</strong> JR, Chuster M. Fun<strong>da</strong>ção Carlos Chagas, Belo Horizonte, v.16:<br />
p.141-155, 1985.<br />
HALLSWORTH, M.P. et al. β2 adrenoceptor agonists inhibit release of eosinophilactivating<br />
cytokines from human airway smooth muscle cells. British Journal of<br />
Pharmacology, Lon<strong>do</strong>n, v.132: p.729-741, 2001.<br />
HIGUCHI, M.L. et al. Pathophysiology of the heart in Chagas’ disease: current status and<br />
new developments. Cardiovascular Research; Lon<strong>do</strong>n, v.60: p.96-107, 2003.<br />
HUNT, S.A.; GIBBONS, R.J.; ANTMAN, E.M. ACC/AHA Guidelines for the evaluation<br />
and management of chronic heart failure in the adult. ACC/AHA Pratice Guidelines,<br />
[s.l.], 2001.<br />
HUNT, S.A. et al. Guideline up<strong>da</strong>te for the diagnosis and management of chronic heart<br />
failure in the adult: a report of the American College of Cardiology/American Heart<br />
131